Morgan Stanley Maintains Overweight on Johnson & Johnson, Raises Price Target to $284

Benzinga Newsdesk www.benzinga.com Positive 85.9%

Neg 0% Neu 0% Pos 85.9%

Morgan Stanley analyst Terence Flynn maintains Johnson & Johnson (NYSE:JNJ) with a Overweight and raises the price target from $283 to $284.